Modern Management of Acute Atrial Fibrillation and Atrial Flutter

Overview

Journal Clin Exp Emerg Med

Specialty Emergency Medicine

Date 2024 Jan 29

PMID 38286500

Authors

Ian G Stiell

Debra Eagles

Affiliations

Soon will be listed here.

References

Stiell I, de Wit K, Scheuermeyer F, Vadeboncoeur A, Angaran P, Eagles D . 2021 CAEP Acute Atrial Fibrillation/Flutter Best Practices Checklist. CJEM. 2021; 23(5):604-610. PMC: 8423652. DOI: 10.1007/s43678-021-00167-y. View

Roy D, Pratt C, Torp-Pedersen C, Wyse D, Toft E, Juul-Moller S . Vernakalant hydrochloride for rapid conversion of atrial fibrillation: a phase 3, randomized, placebo-controlled trial. Circulation. 2008; 117(12):1518-25. DOI: 10.1161/CIRCULATIONAHA.107.723866. View

Atzema C, Jackevicius C, Chong A, Dorian P, Ivers N, Parkash R . Prescribing of oral anticoagulants in the emergency department and subsequent long-term use by older adults with atrial fibrillation. CMAJ. 2019; 191(49):E1345-E1354. PMC: 6901271. DOI: 10.1503/cmaj.190747. View

Stiell I, Eagles D, Nemnom M, Brown E, Taljaard M, Archambault P . Adverse Events Associated With Electrical Cardioversion in Patients With Acute Atrial Fibrillation and Atrial Flutter. Can J Cardiol. 2021; 37(11):1775-1782. DOI: 10.1016/j.cjca.2021.08.018. View

Stiell I, Clement C, Rowe B, Brison R, Wyse D, Birnie D . Outcomes for Emergency Department Patients With Recent-Onset Atrial Fibrillation and Flutter Treated in Canadian Hospitals. Ann Emerg Med. 2017; 69(5):562-571.e2. DOI: 10.1016/j.annemergmed.2016.10.013. View

Stiell I, Healey J, Cairns J . Safety of urgent cardioversion for patients with recent-onset atrial fibrillation and flutter. Can J Cardiol. 2015; 31(3):239-41. DOI: 10.1016/j.cjca.2014.11.027. View

Airaksinen K, Gronberg T, Nuotio I, Nikkinen M, Ylitalo A, Biancari F . Thromboembolic complications after cardioversion of acute atrial fibrillation: the FinCV (Finnish CardioVersion) study. J Am Coll Cardiol. 2013; 62(13):1187-92. DOI: 10.1016/j.jacc.2013.04.089. View

Stiell I, Clement C, Perry J, Vaillancourt C, Symington C, Dickinson G . Association of the Ottawa Aggressive Protocol with rapid discharge of emergency department patients with recent-onset atrial fibrillation or flutter. CJEM. 2010; 12(3):181-91. DOI: 10.1017/s1481803500012227. View

Stiell I, Clement C, Brison R, Rowe B, Borgundvaag B, Langhan T . Variation in management of recent-onset atrial fibrillation and flutter among academic hospital emergency departments. Ann Emerg Med. 2010; 57(1):13-21. DOI: 10.1016/j.annemergmed.2010.07.005. View

10.

Nuotio I, Hartikainen J, Gronberg T, Biancari F, Airaksinen K . Time to cardioversion for acute atrial fibrillation and thromboembolic complications. JAMA. 2014; 312(6):647-9. DOI: 10.1001/jama.2014.3824. View

11.

Stiell I, Macle L . Canadian Cardiovascular Society atrial fibrillation guidelines 2010: management of recent-onset atrial fibrillation and flutter in the emergency department. Can J Cardiol. 2011; 27(1):38-46. DOI: 10.1016/j.cjca.2010.11.014. View

12.

Wyse D, Waldo A, DiMarco J, Domanski M, Rosenberg Y, Schron E . A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med. 2002; 347(23):1825-33. DOI: 10.1056/NEJMoa021328. View

13.

Pluymaekers N, Dudink E, Luermans J, Meeder J, Lenderink T, Widdershoven J . Early or Delayed Cardioversion in Recent-Onset Atrial Fibrillation. N Engl J Med. 2019; 380(16):1499-1508. DOI: 10.1056/NEJMoa1900353. View

14.

Wong B, Perry J, Cheng W, Zheng B, Guo K, Taljaard M . Thromboembolic events following cardioversion of acute atrial fibrillation and flutter: a systematic review and meta-analysis. CJEM. 2021; 23(4):500-511. DOI: 10.1007/s43678-021-00103-0. View

15.

Stiell I, Sivilotti M, Taljaard M, Birnie D, Vadeboncoeur A, Hohl C . Electrical versus pharmacological cardioversion for emergency department patients with acute atrial fibrillation (RAFF2): a partial factorial randomised trial. Lancet. 2020; 395(10221):339-349. DOI: 10.1016/S0140-6736(19)32994-0. View

16.

Guyatt G, Oxman A, Vist G, Kunz R, Falck-Ytter Y, Alonso-Coello P . GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008; 336(7650):924-6. PMC: 2335261. DOI: 10.1136/bmj.39489.470347.AD. View

17.

Stiell I, McMurtry M, McRae A, Parkash R, Scheuermeyer F, Atzema C . The Canadian Cardiovascular Society 2018 guideline update for atrial fibrillation - A different perspective. CJEM. 2019; 21(5):572-575. DOI: 10.1017/cem.2019.399. View

18.

Stiell I, Roos J, Kavanagh K, Dickinson G . A multicenter, open-label study of vernakalant for the conversion of atrial fibrillation to sinus rhythm. Am Heart J. 2010; 159(6):1095-101. DOI: 10.1016/j.ahj.2010.02.035. View

19.

Scheuermeyer F, Andolfatto G, Christenson J, Villa-Roel C, Rowe B . A Multicenter Randomized Trial to Evaluate a Chemical-first or Electrical-first Cardioversion Strategy for Patients With Uncomplicated Acute Atrial Fibrillation. Acad Emerg Med. 2019; 26(9):969-981. DOI: 10.1111/acem.13669. View

20.

Michael J, Stiell I, Agarwal S, Mandavia D . Cardioversion of paroxysmal atrial fibrillation in the emergency department. Ann Emerg Med. 1999; 33(4):379-87. DOI: 10.1016/s0196-0644(99)70300-8. View